CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Loteprednol etabonate

Last Updated: December 2, 2009
Result type: Reports
Project Number: S0186
Product Line: Reimbursement Review

Generic Name: Loteprednol etabonate

Brand Name: Lotemax

Manufacturer: Bausch & Lomb

Indications: Post-operative inflammation following cataract surgery

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: May 19, 2010

Recommendation Type: Do not list